e-Article
Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Document Type
Article
Author
Barta, Stefan K.; Hamdan, Ayad; Boué, François; Delobel, Pierre; Galicier, Lionel; Coppo, Paul; Ghesquières, Hervé; Rubinstein, Paul G ; Moore, Page C; Bimali, Milan; Lee, Jeanette Y; Rudek, Michelle A; Chadburn, Amy; Ratner, Lee; Henry, David H; Cesarman, Ethel; DeMarco, Camille E; Costagliola, Dominique; Taoufik, Yassine; Ramos, Juan Carlos; Sharon, Elad; Reid, Erin G; Ambinder, Richard F; Mitsuyasu, Ronald; Mounier, Nicolas; Besson, Caroline; Noy, Ariela
Source
In The Lancet Haematology August 2023 10(8):e624-e632
Subject
Language
ISSN
2352-3026